deciding on the optimal 1l treatment for patients with advanced rcc
Published 1 year ago • 65 plays • Length 1:22Download video MP4
Download video MP3
Similar videos
-
1:05
cohort 1 litespark-003: belzutifan cabozantinib 1l treatment for advanced rcc
-
2:21
first-line treatment decision making for patients with rcc
-
5:16
potential new treatments in renal cell carcinoma
-
6:27
optimising treatment for advanced rcc: journey through a patient case
-
2:40
updates on the cabopre phase ii trial in patients with metastatic renal cell carcinoma
-
5:10
real-world treatment outcomes of 1l axitinib pembrolizumab in patients with advanced rcc in the us
-
0:42
unmet needs for patients with advanced rcc
-
1:51
the evolving first-line treatment landscape for advanced rcc
-
1:14:23
renal cell carcinoma ( rcc part 3; tnm staging & management)
-
24:40
guidelines based management of localized and locally advanced rcc
-
9:03
renal cell carcinoma/ kidney cancer - signs and symptoms, tnm staging, investigation, treatment
-
38:09
understanding and working with new immunotherapeutic and targeted management models in advanced rcc
-
9:57
how to select 1st line therapy for metastatic renal cell cancer?
-
1:34
unmet needs in the treatment of renal cell carcinoma
-
39:36
management of first line advanced rcc in era of immuno-oncology
-
0:59
dr. zibelman on determining treatments for patients with rcc
-
51:09
immunotherapy-based combinations for advanced/metastatic renal cell carcinoma: asco gu 2023
-
8:15
choosing an io/tki doublet for rcc patients: efficacy data, dosing, and more
-
6:17
in rcc, what is the optimal treatment for intermediate/poor-risk disease?
-
1:04
dr. jonasch on first- and second-line options for patients with rcc
-
5:44
hcrn-gu16-260: nivolumab and salvage nivolumab-ipilimumab in patients with advanced rcc
-
5:29
first- and second-line treatments for locally advanced renal cell carcinoma